Mohammed Abdul Raheem

Title: Mohammed Abdul Raheem: Innovator in Pharmaceutical Chemistry

Introduction

Mohammed Abdul Raheem is a notable inventor based in Brantford, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of zuclomiphene citrate. With a total of 7 patents to his name, Raheem's inventions have the potential to impact the treatment of various medical conditions.

Latest Patents

Raheem's latest patents include novel crystalline forms of zuclomiphene citrate. The present invention provides specific crystalline forms, including zuclomiphene citrate Forms APO-I, APO-II, APO-III, and APO-IV. These forms are accompanied by pharmaceutical compositions that utilize them, as well as processes for their preparation. The applications of these forms extend to treating disorders such as osteoporosis, bone fractures, loss of bone mineral density (BMD), and hot flashes in affected individuals. Additionally, he has developed zuclomiphene salts, including zuclomiphene binaphthyl hydrogen phosphate salt and zuclomiphene oxalate salt, along with their crystalline forms and preparation processes.

Career Highlights

Throughout his career, Raheem has worked with prominent companies in the pharmaceutical industry, including Apotex Pharmachem Inc. and Apotex Inc. His work has been instrumental in advancing pharmaceutical formulations and improving treatment options for patients.

Collaborations

Raheem has collaborated with esteemed colleagues such as Zhi-Xian Wang and Yajun Zhao, contributing to a rich exchange of ideas and innovations in the field.

Conclusion

Mohammed Abdul Raheem's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical applications.